Long-term Electrodiagnostic Changes in Barraquer-Simons Syndrome: A Case Report

Driton Gjukaj; Naser Musli; Margarita G. Todorova

doi:10.1055/a-2040-3480

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2023; 240(04): 532-535
DOI: 10.1055/a-2040-3480

Der interessante Fall

Long-term Electrodiagnostic Changes in Barraquer-Simons Syndrome: A Case Report

Elektrodiagnostische Langzeitveränderungen beim Barraquer-Simons Syndrom: eine Fallvorstellung

Driton Gjukaj‡

¹Department of Ophthalmology, Cantonal Hospital Saint Gallen, Saint Gallen, Switzerland

,

Naser Musli‡

²Faculty of Medicine, University of Zürich, Zürich, Switzerland

,

Margarita G. Todorova

¹Department of Ophthalmology, Cantonal Hospital Saint Gallen, Saint Gallen, Switzerland

³Department of Ophthalmology, University Hospital Basel, Basel, Switzerland

⁴Department of Ophthalmology, University of Zürich, Zürich, Switzerland

› Author Affiliations

Abstract

Full Text

References

References
1 Misra A, Peethambaram A, Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 2004; 83: 18-34
2 Hegele RA, Cao H, Liu DM. et al. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am J Hum Genet 2006; 79: 383-389
3 Miehle K, von Schnurbein J, Fasshauer M. et al. Lipodystrophie-Erkrankungen: Empfehlungen zur Diagnostik und zur Patientenversorgung. Med Genet 2017; 29: 374-388
4 Gaboriau T, Rigalleau V, Rougier MB. et al. Lifelong Progressive Retinal Atrophic Lesions in a Patient with Partial Acquired Lipodystrophy (Barraquer-Simons Syndrome). Retin Cases Brief Rep 2022; 16: 102-105
5 Davis TM, Holdright DR, Schulenberg WE. et al. Retinal pigment epithelial change and partial lipodystrophy. Postgrad Med J 1988; 64: 871-874
6 Jansen J, Delaere L, Spielberg L. et al. Long-term fundus changes in acquired partial lipodystrophy. BMJ Case Rep 2013; 2013: bcr2013201218
7 Sissons JGP, West RJ, Fallows J. et al. The complement abnormalities of lipodystrophy. N Engl J Med 1976; 294: 461-465
8 Dalvin LA, Fervenza FC, Sethi S. et al. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series. Ophthalmology 2016; 123: 1588-1594
9 Appel GB, Cook HT, Hageman G. et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 2005; 16: 1392-1403
10 Framme C, Herboth T, Roider J. et al. [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II]. Klin Monbl Augenheilkd 1998; 213: 252-253
11 Michielsen B, Leys A, Van Damme B. et al. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Doc Ophthalmol 1990; 76: 219-229
12 Ulbig MR, Riordan-Eva P, Holz FG. et al. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am J Ophthalmol 1993; 116: 410-413